# Allemagne – Produits pharmaceutiques – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff FAM OLIMEL (ausgenommen elektrolytfrei;7,6 %; KPG) + austauschbare FAM, ATC B05BA10 f. d. Z. 1.10.26-30.09.28

Acheteur : DAK-Gesundheit.  Pays : Allemagne.  CPV : 33600000.

Source: QUOTA CÔTE — https://quotacote.com/opportunites/allemagne-produits-pharmaceutiques-abschluss-einer-nicht-exklusiven-ra--8dedd835-41b5-467c-bb4c-0d65179a3e32
Last checked by QUOTA: 2026-08-25
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Allemagne [FACT]
- Deadline: 2028-08-04 [FACT]
- Last checked by QUOTA: 2026-08-25 [FACT]
- Sector (QUOTA normalisation): Santé [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Allemagne
- funder: DAK-Gesundheit
- buyer: DAK-Gesundheit

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.